Skip to main content
Top
Published in: BMC Geriatrics 1/2024

Open Access 01-12-2024 | Dementia | Research

Association of 8-hydroxy-2’-deoxyguanosine with motoric cognitive risk in elderly Chinese people: RUGAO longevity and aging cross-sectional study

Authors: Qingqing Dai, Yajun Ma, Chang Liu, Ruixue Zhao, Qi Chen, Weijia Chen, Xiaofeng Wang, Xiaoyan Jiang, Shujuan Li

Published in: BMC Geriatrics | Issue 1/2024

Login to get access

Abstract

Background

Motor cognitive risk syndrome (MCR) represents a critical pre-dementia and disability state characterized by a combination of objectively measured slow walking speed and subjective memory complaints (SMCs). This study aims to identify risk factors for MCR and investigate the relationship between plasma levels of 8-hydroxy-2’-deoxyguanosine (8-OHdG) and MCR among Chinese community-dwelling elderly populations.

Methods

A total of 1312 participants were involved in this study based on the data of the Rugao Longevity and Aging Study (RuLAS). The MCR was characterized by SMCs and slow walking speed. The SCCs were defined as a positive answer to the question ‘Do you feel you have more problems with memory than most?’ in a 15-item Geriatric Depression Scale. Slow walking speed was determined by one standard deviation or more below the mean value of the patient’s age and gender group. The plasma of 8-OHdG were measured by a technician in the biochemistry laboratory of the Rugao People’s Hospital during the morning of the survey.

Results

The prevalence of MCR was found to be 7.9%. After adjusting for covariates, significant associations with MCR were observed in older age (OR 1.057; p = 0.018), history of cerebrovascular disease (OR 2.155; p = 0.010), and elevated 8-OHdG levels (OR 1.007; p = 0.003).

Conclusions

This study indicated the elevated plasma 8-OHdG is significantly associated with increased MCR risk in the elderly, suggesting its potential as a biomarker for early detection and intervention in MCR. This finding underscores the importance of monitoring oxidative DNA damage markers in predicting cognitive and motor function declines, offering new avenues for research and preventive strategies in aging populations.
Literature
1.
go back to reference Kamoga R, Rukundo GZ, Wakida EK, Nakidde G, Obua C, Buss SS. Dementia assessment and diagnostic practices of healthcare workers in rural southwestern Uganda: a cross-sectional qualitative study. BMC Health Serv Res. 2019;19(1):1005.CrossRefPubMedPubMedCentral Kamoga R, Rukundo GZ, Wakida EK, Nakidde G, Obua C, Buss SS. Dementia assessment and diagnostic practices of healthcare workers in rural southwestern Uganda: a cross-sectional qualitative study. BMC Health Serv Res. 2019;19(1):1005.CrossRefPubMedPubMedCentral
2.
go back to reference Verghese J, Wang C, Lipton RB, Holtzer R. Motoric cognitive risk syndrome and the risk of dementia. J Gerontol A Biol Sci Med Sci. 2013;68(4):412–8.CrossRefPubMed Verghese J, Wang C, Lipton RB, Holtzer R. Motoric cognitive risk syndrome and the risk of dementia. J Gerontol A Biol Sci Med Sci. 2013;68(4):412–8.CrossRefPubMed
3.
go back to reference Verghese J, Annweiler C, Ayers E, Barzilai N, Beauchet O, Bennett DA, et al. Motoric cognitive risk syndrome: multicountry prevalence and dementia risk. Neurology. 2014;83(8):718–26.CrossRefPubMedPubMedCentral Verghese J, Annweiler C, Ayers E, Barzilai N, Beauchet O, Bennett DA, et al. Motoric cognitive risk syndrome: multicountry prevalence and dementia risk. Neurology. 2014;83(8):718–26.CrossRefPubMedPubMedCentral
4.
go back to reference Verghese J, Wang C, Bennett DA, Lipton RB, Katz MJ, Ayers E. Motoric cognitive risk syndrome and predictors of transition to dementia: A multicenter study. Alzheimers Dement. 2019;15(7):870–7.CrossRefPubMed Verghese J, Wang C, Bennett DA, Lipton RB, Katz MJ, Ayers E. Motoric cognitive risk syndrome and predictors of transition to dementia: A multicenter study. Alzheimers Dement. 2019;15(7):870–7.CrossRefPubMed
5.
go back to reference Beauchet O, Annweiler C, Callisaya ML, De Cock AM, Helbostad JL, Kressig RW, et al. Poor gait performance and prediction of dementia: results from a meta-analysis. J Am Med Dir Assoc. 2016;17(6):482–90.CrossRefPubMedPubMedCentral Beauchet O, Annweiler C, Callisaya ML, De Cock AM, Helbostad JL, Kressig RW, et al. Poor gait performance and prediction of dementia: results from a meta-analysis. J Am Med Dir Assoc. 2016;17(6):482–90.CrossRefPubMedPubMedCentral
6.
go back to reference Sekhon H, Allali G, Beauchet O. Motoric cognitive risk syndrome and cardiovascular diseases and risk factors in the Canadian population: Results from the baseline assessment of the Canadian longitudinal study on aging. Arch Gerontol Geriatr. 2019;85: 103932.CrossRefPubMed Sekhon H, Allali G, Beauchet O. Motoric cognitive risk syndrome and cardiovascular diseases and risk factors in the Canadian population: Results from the baseline assessment of the Canadian longitudinal study on aging. Arch Gerontol Geriatr. 2019;85: 103932.CrossRefPubMed
7.
go back to reference Verghese J, Ayers E, Barzilai N, Bennett DA, Buchman AS, Holtzer R, et al. Motoric cognitive risk syndrome: Multicenter incidence study. Neurology. 2014;83(24):2278–84.CrossRefPubMedPubMedCentral Verghese J, Ayers E, Barzilai N, Bennett DA, Buchman AS, Holtzer R, et al. Motoric cognitive risk syndrome: Multicenter incidence study. Neurology. 2014;83(24):2278–84.CrossRefPubMedPubMedCentral
8.
go back to reference Jia J, Ning Y, Chen M, Wang S, Yang H, Li F, et al. Biomarker Changes during 20 Years Preceding Alzheimer’s Disease. N Engl J Med. 2024;390(8):712–22.CrossRefPubMed Jia J, Ning Y, Chen M, Wang S, Yang H, Li F, et al. Biomarker Changes during 20 Years Preceding Alzheimer’s Disease. N Engl J Med. 2024;390(8):712–22.CrossRefPubMed
9.
go back to reference Biswas SK. Does the Interdependence between Oxidative Stress and Inflammation Explain the Antioxidant Paradox? Oxid Med Cell Longev. 2016;2016:5698931.CrossRefPubMedPubMedCentral Biswas SK. Does the Interdependence between Oxidative Stress and Inflammation Explain the Antioxidant Paradox? Oxid Med Cell Longev. 2016;2016:5698931.CrossRefPubMedPubMedCentral
10.
go back to reference Wang XX, Zhang B, Xia R, Jia QY. Inflammation, apoptosis and autophagy as critical players in vascular dementia. Eur Rev Med Pharmacol Sci. 2020;24(18):9601–14.PubMed Wang XX, Zhang B, Xia R, Jia QY. Inflammation, apoptosis and autophagy as critical players in vascular dementia. Eur Rev Med Pharmacol Sci. 2020;24(18):9601–14.PubMed
11.
go back to reference de Laat KF, Reid AT, Grim DC, Evans AC, Kotter R, van Norden AG, de Leeuw FE. Cortical thickness is associated with gait disturbances in cerebral small vessel disease. Neuroimage. 2012;59(2):1478–84.CrossRefPubMed de Laat KF, Reid AT, Grim DC, Evans AC, Kotter R, van Norden AG, de Leeuw FE. Cortical thickness is associated with gait disturbances in cerebral small vessel disease. Neuroimage. 2012;59(2):1478–84.CrossRefPubMed
12.
go back to reference Groeger JL, Ayers E, Barzilai N, Beauchet O, Callisaya M, Torossian MR, et al. Inflammatory biomarkers and motoric cognitive risk syndrome: Multicohort survey. Cereb Circ Cogn Behav. 2022;3: 100151.PubMedPubMedCentral Groeger JL, Ayers E, Barzilai N, Beauchet O, Callisaya M, Torossian MR, et al. Inflammatory biomarkers and motoric cognitive risk syndrome: Multicohort survey. Cereb Circ Cogn Behav. 2022;3: 100151.PubMedPubMedCentral
13.
go back to reference Radi E, Formichi P, Battisti C, Federico A. Apoptosis and oxidative stress in neurodegenerative diseases. J Alzheimers Dis. 2014;42(Suppl 3):S125–52.CrossRefPubMed Radi E, Formichi P, Battisti C, Federico A. Apoptosis and oxidative stress in neurodegenerative diseases. J Alzheimers Dis. 2014;42(Suppl 3):S125–52.CrossRefPubMed
14.
go back to reference Savic-Radojevic A, Pljesa-Ercegovac M, Matic M, Simic D, Radovanovic S, Simic T. Novel Biomarkers of Heart Failure. Adv Clin Chem. 2017;79:93–152.CrossRefPubMed Savic-Radojevic A, Pljesa-Ercegovac M, Matic M, Simic D, Radovanovic S, Simic T. Novel Biomarkers of Heart Failure. Adv Clin Chem. 2017;79:93–152.CrossRefPubMed
15.
go back to reference Liu Z, Cai Y, He J. High serum levels of 8-OHdG are an independent predictor of post-stroke depression in Chinese stroke survivors. Neuropsychiatr Dis Treat. 2018;14:587–96.CrossRefPubMedPubMedCentral Liu Z, Cai Y, He J. High serum levels of 8-OHdG are an independent predictor of post-stroke depression in Chinese stroke survivors. Neuropsychiatr Dis Treat. 2018;14:587–96.CrossRefPubMedPubMedCentral
16.
go back to reference Cao P, Zhang C, Hua DX, Li MD, Lv BB, Fu L, Zhao H. Serum 8-Hydroxy-2’-deoxyguanosine predicts severity and prognosis of patients with acute exacerbation of chronic obstructive pulmonary disease. Lung. 2022;200(1):31–9.CrossRefPubMed Cao P, Zhang C, Hua DX, Li MD, Lv BB, Fu L, Zhao H. Serum 8-Hydroxy-2’-deoxyguanosine predicts severity and prognosis of patients with acute exacerbation of chronic obstructive pulmonary disease. Lung. 2022;200(1):31–9.CrossRefPubMed
17.
go back to reference Pena-Bautista C, Tirle T, Lopez-Nogueroles M, Vento M, Baquero M, Chafer-Pericas C. Oxidative Damage of DNA as Early Marker of Alzheimer's Disease. Int J Mol Sci. 2019;20(24). Pena-Bautista C, Tirle T, Lopez-Nogueroles M, Vento M, Baquero M, Chafer-Pericas C. Oxidative Damage of DNA as Early Marker of Alzheimer's Disease. Int J Mol Sci. 2019;20(24).
18.
go back to reference Liu Z, Wang Y, Zhang Y, Chu X, Wang Z, Qian D, et al. Cohort Profile: The Rugao Longevity and Ageing Study (RuLAS). Int J Epidemiol. 2016;45(4):1064–73.PubMed Liu Z, Wang Y, Zhang Y, Chu X, Wang Z, Qian D, et al. Cohort Profile: The Rugao Longevity and Ageing Study (RuLAS). Int J Epidemiol. 2016;45(4):1064–73.PubMed
19.
go back to reference Yesavage JA. Geriatric Depression Scale. Psychopharmacol Bull. 1988;24(4):709–11.PubMed Yesavage JA. Geriatric Depression Scale. Psychopharmacol Bull. 1988;24(4):709–11.PubMed
20.
go back to reference Zhang L, Feng BL, Wang CY, Zhang Y, Lin P, Zhang YL, et al. Prevalence and factors associated with motoric cognitive risk syndrome in community-dwelling older Chinese: a cross-sectional study. Eur J Neurol. 2020;27(7):1137–45.CrossRefPubMed Zhang L, Feng BL, Wang CY, Zhang Y, Lin P, Zhang YL, et al. Prevalence and factors associated with motoric cognitive risk syndrome in community-dwelling older Chinese: a cross-sectional study. Eur J Neurol. 2020;27(7):1137–45.CrossRefPubMed
21.
go back to reference Doi T, Verghese J, Shimada H, Makizako H, Tsutsumimoto K, Hotta R, et al. Motoric Cognitive Risk Syndrome: Prevalence and Risk Factors in Japanese Seniors. J Am Med Dir Assoc. 2015;16(12):1103 e21–5. Doi T, Verghese J, Shimada H, Makizako H, Tsutsumimoto K, Hotta R, et al. Motoric Cognitive Risk Syndrome: Prevalence and Risk Factors in Japanese Seniors. J Am Med Dir Assoc. 2015;16(12):1103 e21–5.
22.
go back to reference Liu Z, Liu Y, Tu X, Shen H, Qiu H, Chen H, He J. High Serum Levels of Malondialdehyde and 8-OHdG are both Associated with Early Cognitive Impairment in Patients with Acute Ischaemic Stroke. Sci Rep. 2017;7(1):9493.CrossRefPubMedPubMedCentral Liu Z, Liu Y, Tu X, Shen H, Qiu H, Chen H, He J. High Serum Levels of Malondialdehyde and 8-OHdG are both Associated with Early Cognitive Impairment in Patients with Acute Ischaemic Stroke. Sci Rep. 2017;7(1):9493.CrossRefPubMedPubMedCentral
23.
go back to reference Mecocci P, MacGarvey U, Kaufman AE, Koontz D, Shoffner JM, Wallace DC, Beal MF. Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. Ann Neurol. 1993;34(4):609–16.CrossRefPubMed Mecocci P, MacGarvey U, Kaufman AE, Koontz D, Shoffner JM, Wallace DC, Beal MF. Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. Ann Neurol. 1993;34(4):609–16.CrossRefPubMed
24.
go back to reference Mecocci P, Boccardi V, Cecchetti R, Bastiani P, Scamosci M, Ruggiero C, Baroni M. A long journey into aging, brain aging, and alzheimer’s disease following the oxidative stress tracks. J Alzheimers Dis. 2018;62(3):1319–35.CrossRefPubMedPubMedCentral Mecocci P, Boccardi V, Cecchetti R, Bastiani P, Scamosci M, Ruggiero C, Baroni M. A long journey into aging, brain aging, and alzheimer’s disease following the oxidative stress tracks. J Alzheimers Dis. 2018;62(3):1319–35.CrossRefPubMedPubMedCentral
25.
go back to reference Huang TF, Tang ZP, Wang S, Hu MW, Zhan L, Yi Y, et al. Decrease in Serum Levels of Adiponectin and Increase in 8-OHdG: a Culprit for Cognitive Impairment in the Elderly Patients with Type 2 Diabetes. Curr Mol Med. 2019;20(1):44–50.CrossRefPubMed Huang TF, Tang ZP, Wang S, Hu MW, Zhan L, Yi Y, et al. Decrease in Serum Levels of Adiponectin and Increase in 8-OHdG: a Culprit for Cognitive Impairment in the Elderly Patients with Type 2 Diabetes. Curr Mol Med. 2019;20(1):44–50.CrossRefPubMed
26.
go back to reference Moslemnezhad A, Mahjoub S, Moghadasi M. Altered plasma marker of oxidative DNA damage and total antioxidant capacity in patients with Alzheimer’s disease. Caspian J Intern Med. 2016;7(2):88–92.PubMedPubMedCentral Moslemnezhad A, Mahjoub S, Moghadasi M. Altered plasma marker of oxidative DNA damage and total antioxidant capacity in patients with Alzheimer’s disease. Caspian J Intern Med. 2016;7(2):88–92.PubMedPubMedCentral
27.
28.
go back to reference Grande G, Triolo F, Nuara A, Welmer AK, Fratiglioni L, Vetrano DL. Measuring gait speed to better identify prodromal dementia. Exp Gerontol. 2019;124: 110625.CrossRefPubMed Grande G, Triolo F, Nuara A, Welmer AK, Fratiglioni L, Vetrano DL. Measuring gait speed to better identify prodromal dementia. Exp Gerontol. 2019;124: 110625.CrossRefPubMed
29.
go back to reference Meiner Z, Ayers E, Verghese J. Motoric cognitive risk syndrome: a risk factor for cognitive impairment and dementia in different populations. Ann Geriatr Med Res. 2020;24(1):3–14.CrossRefPubMedPubMedCentral Meiner Z, Ayers E, Verghese J. Motoric cognitive risk syndrome: a risk factor for cognitive impairment and dementia in different populations. Ann Geriatr Med Res. 2020;24(1):3–14.CrossRefPubMedPubMedCentral
30.
go back to reference Wiesmeier IK, Dalin D, Wehrle A, Granacher U, Muehlbauer T, Dietterle J, et al. Balance training enhances vestibular function and reduces overactive proprioceptive feedback in elderly. Front Aging Neurosci. 2017;9:273.CrossRefPubMedPubMedCentral Wiesmeier IK, Dalin D, Wehrle A, Granacher U, Muehlbauer T, Dietterle J, et al. Balance training enhances vestibular function and reduces overactive proprioceptive feedback in elderly. Front Aging Neurosci. 2017;9:273.CrossRefPubMedPubMedCentral
31.
go back to reference Ferrazzoli D, Ortelli P, Madeo G, Giladi N, Petzinger GM, Frazzitta G. Basal ganglia and beyond: The interplay between motor and cognitive aspects in Parkinson’s disease rehabilitation. Neurosci Biobehav Rev. 2018;90:294–308.CrossRefPubMed Ferrazzoli D, Ortelli P, Madeo G, Giladi N, Petzinger GM, Frazzitta G. Basal ganglia and beyond: The interplay between motor and cognitive aspects in Parkinson’s disease rehabilitation. Neurosci Biobehav Rev. 2018;90:294–308.CrossRefPubMed
32.
go back to reference Beauchet O, Allali G, Annweiler C, Verghese J. Association of motoric cognitive risk syndrome with brain volumes: results from the GAIT study. J Gerontol A Biol Sci Med Sci. 2016;71(8):1081–8.CrossRefPubMed Beauchet O, Allali G, Annweiler C, Verghese J. Association of motoric cognitive risk syndrome with brain volumes: results from the GAIT study. J Gerontol A Biol Sci Med Sci. 2016;71(8):1081–8.CrossRefPubMed
33.
go back to reference Sathyan S, Barzilai N, Atzmon G, Milman S, Ayers E, Verghese J. Association of anti-inflammatory cytokine IL10 polymorphisms with motoric cognitive risk syndrome in an Ashkenazi Jewish population. Neurobiol Aging. 2017;58(238):e1–8. Sathyan S, Barzilai N, Atzmon G, Milman S, Ayers E, Verghese J. Association of anti-inflammatory cytokine IL10 polymorphisms with motoric cognitive risk syndrome in an Ashkenazi Jewish population. Neurobiol Aging. 2017;58(238):e1–8.
34.
go back to reference Kumar P, Liu C, Hsu JW, Chacko S, Minard C, Jahoor F, Sekhar RV. Glycine and N-acetylcysteine (GlyNAC) supplementation in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, insulin resistance, endothelial dysfunction, genotoxicity, muscle strength, and cognition: Results of a pilot clinical trial. Clin Transl Med. 2021;11(3): e372.CrossRefPubMedPubMedCentral Kumar P, Liu C, Hsu JW, Chacko S, Minard C, Jahoor F, Sekhar RV. Glycine and N-acetylcysteine (GlyNAC) supplementation in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, insulin resistance, endothelial dysfunction, genotoxicity, muscle strength, and cognition: Results of a pilot clinical trial. Clin Transl Med. 2021;11(3): e372.CrossRefPubMedPubMedCentral
35.
go back to reference Jia J, Zhao T, Liu Z, Liang Y, Li F, Li Y, et al. Association between healthy lifestyle and memory decline in older adults: 10 year, population based, prospective cohort study. BMJ. 2023;380: e072691.CrossRefPubMedPubMedCentral Jia J, Zhao T, Liu Z, Liang Y, Li F, Li Y, et al. Association between healthy lifestyle and memory decline in older adults: 10 year, population based, prospective cohort study. BMJ. 2023;380: e072691.CrossRefPubMedPubMedCentral
Metadata
Title
Association of 8-hydroxy-2’-deoxyguanosine with motoric cognitive risk in elderly Chinese people: RUGAO longevity and aging cross-sectional study
Authors
Qingqing Dai
Yajun Ma
Chang Liu
Ruixue Zhao
Qi Chen
Weijia Chen
Xiaofeng Wang
Xiaoyan Jiang
Shujuan Li
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2024
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-024-04943-0

Other articles of this Issue 1/2024

BMC Geriatrics 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine